stockrowLiquidia Corporation
LQDA Healthcare Drug Manufacturers Specialty & Generic
Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.
- Revenue
- +1,842.7%
- EPS
- +271.4%
- Free cash flow
- +270.2%
- Total debt
- −9.04%
Quarter to June 2026, against a year earlier
Follow LQDA
Alert me
Liquidia Corporation (LQDA) Total debt
Liquidia Corporation's total debt at the end of fiscal 2025 was $191.3M, up 68.9% from $113.3M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $176.1M. Over the past ten years it has ranged from $1.1M (fiscal 2022) to $191.3M (fiscal 2025) — the current reading is the highest in ten years. Liquidia Corporation ranks 31st of 84 Drug Manufacturers Specialty & Generic companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $191.3M | 68.90% |
| FY2024 | $113.3M | 146.09% |
| FY2023 | $46.0M | 129.59% |
| FY2022 | $20.1M | 1,754.76% |
| FY2022 | $1.1M | (89.96%) |
| FY2021 | $10.8M | 891.43% |
| FY2021 | $1.1M | (89.71%) |
| FY2020 | $10.5M | 564.27% |
| FY2020 | $1.6M | (90.62%) |
| FY2019 | $16.9M | (30.64%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $176.1M | (0.99%) |
| Mar 2026 | $177.9M | (7.04%) |
| Dec 2025 | $191.3M | (0.60%) |
| Sep 2025 | $192.5M | (0.57%) |
| 26 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | $3.2B |
| PBH Prestige Consumer Healthcare Inc. compare | $2.0B |
| HIMS Hims & Hers Health, Inc. compare | $1.4B |
| LNTH Lantheus Holdings, Inc. compare | $571.7M |
| SUPN Indivior Pharmaceuticals Inc. compare | $488.0M |
| LQDA Liquidia Corporation | $176.1M |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | $94.5M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | $1.4M |
| RGC Regencell Bioscience Holdings Limited compare | $463.7K |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on LQDA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement